marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Diffusion Pharmaceuticals Financial Ratios 2011-2024 | DFFN
Annual Financial Ratios Diffusion Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-5.4 | -0.5 | -1.1 | -4.3 | -0.2 | -0.4 | -5.8 | -1.8 | - | -3.1 | -3.2 | -2.8 | -4.4 |
P/S |
1.6 | - | - | - | - | - | - | - | - | - | 110.8 | 52.7 | 121.1 |
EPS |
-0.8 | -11.2 | -12.4 | -0.3 | -1.8 | -8.2 | -3.2 | -1.8 | -1.3 | -1 | -1 | -0.1 | -0.2 |
EV (Enterprise Value) |
6.51 M | 12 M | -6.87 M | 45.8 M | -7.38 M | 1.54 M | 3.99 M | 39.5 M | 7.82 B | 27.3 M | 19.6 M | 40 M | 72.7 M |
EBITDA per Share |
-2.94 | -6.71 | -12.1 | -0.295 | -1.71 | -3.68 | -13.6 | -26.9 | - | -77.4 | -344 | -669 | -1.45 K |
EV/EBITDA |
-52.4 | -2.7 | 1.0 | 0.1 | 0.0 | -1.8 | - | -3.1 | -1.6 | -39.2 | -4.3 | ||
PEG |
-0.01 | -0.0 | -0.0 | 0.21 | -0.0 | 0.0 | -0.07 | -0.02 | - | 0.03 | 0.0 | 0.0 | 0.0 |
P/B |
1.6 | -0.3 | 0.8 | 2.5 | 0.1 | 0.4 | 0.4 | 3.6 | 221.8 | 1.2 | 1.2 | -1.1 | -985.7 |
P/CF |
-1.6 | -1.1 | -1.9 | -4.5 | -0.3 | -0.6 | -0.6 | -3.0 | - | -4.9 | -6.7 | -4.5 | -5.7 |
ROE % |
-29.44 | 17.43 | -69.02 | -57.17 | -58.60 | -117.67 | -6.43 | -196.38 | - | -37.61 | -38.16 | 37.25 | 22628.57 |
ROA % |
-21.78 | -139.57 | -63.68 | -51.16 | -48.94 | -100.92 | -5.22 | -103.16 | - | -33.55 | -13.43 | -279.59 | -431.61 |
ROCE % |
-105.91 | 10.44 | -70.68 | -63.16 | -51.60 | -69.14 | -48.38 | -140.82 | - | -19.64 | -25.97 | 37.23 | 13200.00 |
Current Ratio |
3.8 | 0.3 | 12.9 | 7.7 | 8.5 | 11.1 | 3.6 | 0.4 | 10.0 | 10.3 | 0.3 | 0.0 | 0.1 |
DSO |
- | - | - | - | - | - | - | - | - | - | 10.3 | 69.1 | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | 1825.0 | 124.8 |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | 69.1 | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | -1755.9 | -124.8 |
All numbers in USD currency
Quarterly Financial Ratios Diffusion Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.55 | -0.27 | -0.41 | - | 0.65 | -2.75 | -1.03 | - | -1.7 | -2.06 | -2.22 | - | -5.99 | -1.85 | -2.81 | - | -0.07 | -0.1 | -0.07 | - | -0.6 | -0.63 | -0.81 | - | -1.99 | -0.82 | -4.11 | - | 0.21 | 0.88 | -2.78 | - | -0.53 | -0.37 | -0.62 | - | -0.64 | -0.06 | -0.06 | - | -0.18 | -0.35 | -0.23 | - | -0.37 | 0.82 | -2.91 | - | -0.04 | -0.24 | - | - | -0.06 | -0.03 | - |
EBITDA per Share |
- | - | - | - | - | - | - | - | -1.74 | -2.08 | -2.23 | - | -6.2 | -1.86 | -2.82 | - | -0.08 | -0.06 | 0.05 | - | -0.09 | -0.08 | -0.09 | - | -0.14 | -0.06 | -0.08 | - | -0.24 | -0.27 | -0.25 | - | -0.56 | -0.37 | -0.62 | - | -0.07 | -0.07 | -0.06 | - | -0.17 | -0.11 | -0.2 | - | -0.28 | -1.39 | -0.36 | - | -0.04 | -0.04 | -0.03 | - | -0.05 | -0.03 | - |
ROE % |
-39.71 | -6.83 | 1.86 | 28.10 | 30.88 | 11.19 | -8.59 | -27.72 | -59.72 | -94.48 | -86.30 | -48.18 | -66.07 | -51.97 | -57.03 | -40.80 | -54.72 | -50.76 | -50.56 | -39.97 | -83.01 | -112.13 | -117.45 | -81.98 | -57.98 | 9.08 | 122.82 | -14.86 | -74.05 | -157.25 | -294.72 | -168.39 | 3249.47 | 6726.53 | 9966.03 | 9603.42 | 9595.36 | 6169.43 | 2961.54 | -29.19 | -52.81 | -68.36 | -22.18 | -25.62 | -6.78 | 35.68 | 6.53 | 27.61 | 3050.68 | 6054.91 | 17089.46 | - | 3023.07 | 11041.74 | - |
ROA % |
-27.66 | -0.07 | -38.09 | -38.06 | -41.41 | -62.63 | -34.61 | -31.19 | -61.04 | -87.52 | -80.33 | -45.27 | -61.28 | -47.45 | -51.55 | -36.51 | -48.14 | -43.76 | -42.84 | -33.38 | -70.29 | -95.58 | -100.42 | -70.32 | -50.82 | 5.59 | 98.76 | -12.06 | -43.16 | -93.75 | -193.49 | -88.46 | -150.94 | -182.34 | -219.04 | -175.58 | -183.64 | -129.22 | -81.16 | -21.70 | -30.02 | -30.27 | -7.06 | -9.02 | -150.64 | -283.95 | -350.79 | -207.56 | -325.60 | -302.00 | -679.07 | - | -118.03 | -431.11 | - |
ROCE % |
-94.39 | -110.50 | -101.00 | -20.21 | -17.37 | 13.41 | -6.02 | -27.96 | -61.25 | -97.38 | -89.10 | -49.66 | -70.92 | -58.88 | -65.98 | -24.09 | -39.25 | -33.15 | -31.43 | -42.67 | -87.33 | -116.84 | -123.54 | -85.85 | -101.61 | -72.71 | -67.03 | -41.90 | -105.04 | -152.43 | -179.76 | -172.28 | 3062.59 | 6360.60 | 9519.94 | 9218.25 | 9210.05 | 5966.98 | 2845.03 | -23.41 | -49.17 | -66.73 | -188.12 | -183.53 | -164.90 | -120.50 | 23.50 | 50.06 | 2936.68 | 5804.67 | 7220.00 | - | 2886.62 | 1433.96 | - |
Current Ratio |
15.1 | 16.6 | 3.0 | 3.8 | 4.9 | 0.2 | 1.9 | 0.3 | - | - | - | 12.9 | 14.9 | 20.7 | 21.9 | 9.5 | 9.5 | 9.5 | 9.5 | 6.1 | 6.1 | 6.1 | 6.1 | 7.0 | 7.0 | 7.0 | 7.0 | 5.3 | 5.3 | 5.3 | 5.3 | 2.1 | 2.1 | 2.1 | 2.1 | 1.0 | 1.0 | 1.0 | 1.0 | 9.3 | 9.3 | 9.3 | 9.3 | 1.5 | 1.5 | 1.5 | - | - | - | - | - | 1.0 | 0.9 | 1.0 | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 22.8 | 45.6 | - | - | 20.4 | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 129186.6 | 17022.0 | 397.8 | - | 283.7 | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 22.8 | 45.6 | - | - | 20.4 | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -129163.8 | -16976.3 | -397.8 | - | -263.2 | - | - |
All numbers in USD currency